Diversified Trust’s Arcus Biosciences RCUS Stock Holding History

Diversified Trust’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$662K	Buy	+25,639	New	+$723K	0.01%	593
2024 Q3	–	Sell	-13,545	Closed	-$206K	–	957
2024 Q2	$206K	Buy	13,545 +1,467	+12%	+$23.7K	0.01%	781
2024 Q1	$228K	Buy	+12,078	New	+$209K	0.01%	720
2022 Q4	–	Sell	-8,645	Closed	-$226K	–	844
2022 Q3	$226K	Sell	8,645 -382	-4%	-$10.1K	0.01%	658
2022 Q2	$229K	Hold	9,027	–	–	0.01%	649
2022 Q1	$285K	Hold	9,027	–	–	0.01%	641
2021 Q4	$365K	Buy	9,027 +599	+7%	+$23.2K	0.01%	563
2021 Q3	$294K	Hold	8,428	–	–	0.01%	603
2021 Q2	$231K	Hold	8,428	–	–	0.01%	656
2021 Q1	$237K	Buy	+8,428	New	+$293K	0.01%	632

Other funds holding RCUS

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

Diversified Trust's RCUS Position: Q3 2026 in Review

Diversified Trust opened a new position in Arcus Biosciences (RCUS) in Q3 2026: 25,639 shares worth $662K. The stake represents 0.01% of the portfolio and ranks #593 among its holdings. This is a return to the name: Diversified Trust previously reported a position in RCUS as recently as Q2 2024.

Diversified Trust first reported a position in RCUS in Q1 2021 and has held it in 10 quarters since. 107 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

Diversified Trust held 25,639 shares of Arcus Biosciences worth $662K as of Q3 2026.
Arcus Biosciences was a new Diversified Trust position in Q3 2026.
Arcus Biosciences made up 0.01% of Diversified Trust's portfolio in Q3 2026, its #593 holding.
Diversified Trust first reported a position in Arcus Biosciences in Q1 2021 and has held it in 10 quarters since.
107 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Diversified Trust's 13F filing for Q3 2026, filed 6 Nov 2026.